References

¹Institute of Medicine. Microbial Threats to Health: Emergence, Detection, and Response. Washington, DC: National Academies Press, 2003.

²Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP). More information available at www.cdc.gov/nip/acip/; accessed October 31, 2006.

³U.S. Department of Health and Human Services (HHS). VAERS: Vaccine Adverse Event Reporting System. More information available at http://vaers.hhs.gov/; accessed October 31, 2006.

⁴Incidence from 2000–2004: Unpublished data, CDC National Notifiable Disease Surveillance System.

⁵ CDC. Early-onset and late-onset neonatal group B streptococcal disease—United States, 1996–2004. Morbidity and Mortality Weekly Report 54:1205–1208, 2005.

⁶CDC. Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC. Morbidity and Mortality Weekly Report 51(RR–11), 2002.

⁷The Emerging Infections Program (EIP) Network is a multistate-CDC cooperative agreement that had 11 States participating in 2005. Collaborating health departments in EIP, academic institutions, and CDC staff members coordinate population-based surveillance for selected pathogens, including group B streptococcus, and use this infrastructure to conduct epidemiologic studies with a focus on guiding and evaluating prevention efforts in public health.

⁸Wong, E.S. Guideline for Prevention of Catheter-Associated Urinary Tract Infections. CDC. February 1981. (Revised March 1982). More information available at www.cdc.gov/ncidod/dhqp/gl_catheter_assoc.html; accessed October 31, 2006.

⁹CDC. Measles—United States, 2000. Morbidity and Mortality Weekly Report 51(06):120–123, 2002.

¹⁰CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. Morbidity and Mortality Weekly Report 55(RR-16), 2006. More information available at www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a1.htm; accessed October 31, 2006.

¹¹CDC. National Hepatitis C Prevention Strategy. More information available at http://www.cdc.gov/ncidod/diseases/hepatitis/c/plan/strategy.pdf; accessed October 31, 2006.

¹²CDC. Trends in tuberculosis—United States, 1998–2003. Morbidity and Mortality Weekly Report 53:209–214, 2004.

¹³U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, VA: International Medical Publishing, 1996.

¹⁴Sobel, J., et al. Helicobacter pylori seroprevalence in the U.S. population has markedly decreased in the decade between NHANES III and NHANES 1999–2000. Programs and Abstracts of the Infectious Diseases Society of America 41st Annual Meeting. [Abstract 865.] Alexandria, VA: Infectious Diseases Society of America, 2003.

¹⁵The "Get Smart" campaign is a CDC-developed national program that promotes appropriate antibiotic use in the community. CDC partners with States and plans to expand its partnerships to include pharmacists and employers.

¹⁶CDC. Direct and indirect effects of routine immunization with 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease—United States, 1998–2003. Morbidity and Mortality Weekly Report 36(9):54, 2005.

¹⁷CDC. Summary of notifiable diseases—2003. Morbidity and Mortality Weekly Report 52(54):1–85, 2005.

¹⁸CDC. Stereotyping discrepancies in Haemophilus influenzae type b disease―United States, 1998–1999. Morbidity and Mortality Weekly Report 51(32):706–707, 2002. More information available at www.cdc.gov/mmwr/preview/mmwrhtml/mm5132a3.htm; accessed October 31, 2006.

¹⁹More information about the ACIP recommendations is available at www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a1.htm?s_cid=rr5503a1_; accessed October 31, 2006.

²⁰More information available at www.cdc.gov/ncidod/diseases/hepatitis/msm/index.htm; accessed October 31, 2006.

²¹Schrag, S.J., et al. Limiting the spread of resistant pneumococci: Biological and epidemiologic evidence for the effectiveness of alternative interventions. Clinical Microbiology Reviews 13:588–601, 2000.

²²More information available at www.cdc.gov/ncidod/dvbid/lyme/ld_prevent.htm; accessed October 31, 2006.

²³CDC. The Childhood Immunization Initiative. HHS Fact Sheet. More information available at www.hhs.gov/news/press/2000pres/20000706a.html; accessed October 31, 2006.

²⁴Hutchins, S.S., et al. Elimination of measles and of disparities in measles childhood vaccine coverage among racial and ethnic minority populations in the United States. Journal of Infectious Diseases (Suppl 1):S146–S152, 2003.

²⁵Hutchins, S.S., and Bernier, R. Childhood Vaccination and Disparities. Paper presented at National Leadership Summit on Eliminating Racial and Ethnic Disparities in Health. January 9, 2006. Washington, DC: HHS, Office of Minority Health.

²⁶Reef, S.E., et al. The epidemiology of rubella and CRS in the United States from 1998–2004: The evidence for absence of endemic transmission. Clinical Infectious Diseases (Suppl, in press, scheduled for October 2006).

²⁷CDC. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 55(RR-7):1–23, 2006. More information available at www.cdc.gov/mmwr/preview/mmwrhtml/rr5507a1.htm; accessed October 31, 2006.

²⁸More information available at www.cdc.gov/nip/vfc/acip_resolutions/1005-1hepa.pdf; accessed October 31, 2006.

²⁹More information available at www.cdc.gov/nip/vfc/acip_resolutions/1003hepb.pdf; accessed October 31, 2006.

³⁰Wasley, A., et al. Incidence of hepatitis A in the United States in the era of vaccination. Journal of the American Medical Association 294:194–201, 2005.

³¹Wasley, A., et al. Hepatitis A Among U.S. Children in the Era of Vaccination. [Abstract.] 43rd Annual Meeting of Infectious Diseases Society of America, San Francisco, October 6–9, 2005.

³²Flannery, B., et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. Journal of the American Medical Association 291(18):2197–2203, 2004.

³³Schneider, E., et al. Epidemiology of tuberculosis in the United States. Clinics in Chest Medicine 26:183–195, 2005.

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.

<<  Previous—Objectives and Subobjectives  |  Table of Contents |  Next—Related Objectives From Other Focus Areas >>